JAMA Dermatology
@jamadermatology.com
JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
🌐 JAMADermatology.com
🌐 JAMADermatology.com
JAK inhibitor exposure was not associated with reduced height in children treated for atopic dermatitis, juvenile arthritis, or inflammatory bowel disease. ja.ma/4bAXdZN
January 25, 2026 at 1:00 PM
JAK inhibitor exposure was not associated with reduced height in children treated for atopic dermatitis, juvenile arthritis, or inflammatory bowel disease. ja.ma/4bAXdZN
Among adults with #AtopicDermatitis, JAK inhibitor use was associated with more than double the 6-month risk of physician-recorded #Acne compared with Th2 cytokine inhibitor, with no difference seen for folliculitis or rosacea. ja.ma/4sYz6dt
January 24, 2026 at 3:00 PM
Among adults with #AtopicDermatitis, JAK inhibitor use was associated with more than double the 6-month risk of physician-recorded #Acne compared with Th2 cytokine inhibitor, with no difference seen for folliculitis or rosacea. ja.ma/4sYz6dt
#Acne prevalence among transmasculine patients ranged from 29.6% to 61.9% depending on methodology.
📌 This Review aims to summarize current literature for prevalence and factors associated with acne in transmasculine patients.
ja.ma/49D2xKz
📌 This Review aims to summarize current literature for prevalence and factors associated with acne in transmasculine patients.
ja.ma/49D2xKz
January 24, 2026 at 2:00 PM
#Acne prevalence among transmasculine patients ranged from 29.6% to 61.9% depending on methodology.
📌 This Review aims to summarize current literature for prevalence and factors associated with acne in transmasculine patients.
ja.ma/49D2xKz
📌 This Review aims to summarize current literature for prevalence and factors associated with acne in transmasculine patients.
ja.ma/49D2xKz
This case report describes a man in his 30s who was referred for the evaluation of a 3-month destructive process affecting the nail matrix and nail plate of the left thumbnail. ja.ma/3NssHat
January 23, 2026 at 2:00 PM
This case report describes a man in his 30s who was referred for the evaluation of a 3-month destructive process affecting the nail matrix and nail plate of the left thumbnail. ja.ma/3NssHat
Seborrheic #dermatitis in adults is positively associated with a range of other epithelial barrier diseases, including atopic dermatitis, #psoriasis, #rosacea, #celiac disease, and dry eye.
ja.ma/49Mg7dq
ja.ma/49Mg7dq
January 23, 2026 at 1:00 PM
Seborrheic #dermatitis in adults is positively associated with a range of other epithelial barrier diseases, including atopic dermatitis, #psoriasis, #rosacea, #celiac disease, and dry eye.
ja.ma/49Mg7dq
ja.ma/49Mg7dq
Moderate to severe #Acne incidence was greatest within the first year after testosterone for transmasculine individuals vs cisgender comparators.
ja.ma/3ZucdRy
ja.ma/3ZucdRy
January 22, 2026 at 3:00 PM
Moderate to severe #Acne incidence was greatest within the first year after testosterone for transmasculine individuals vs cisgender comparators.
ja.ma/3ZucdRy
ja.ma/3ZucdRy
Specific T-cell receptor clonotypes, especially Vb20 and Vg8, were associated with advanced-stage disease and poor survival in MF/SS. ja.ma/4abQiE3
January 22, 2026 at 1:00 PM
Specific T-cell receptor clonotypes, especially Vb20 and Vg8, were associated with advanced-stage disease and poor survival in MF/SS. ja.ma/4abQiE3
Discordance between clinician- and patient-reported outcomes is common in Skin Chronic Graft-vs-Host Disease.
Ade Adamson, MD, speaks with author Emily Baumrin, MD, MSCE, about how patient-reported measures may better predict survival.
Listen now: ja.ma/49M1vdV
Ade Adamson, MD, speaks with author Emily Baumrin, MD, MSCE, about how patient-reported measures may better predict survival.
Listen now: ja.ma/49M1vdV
January 21, 2026 at 5:00 PM
Discordance between clinician- and patient-reported outcomes is common in Skin Chronic Graft-vs-Host Disease.
Ade Adamson, MD, speaks with author Emily Baumrin, MD, MSCE, about how patient-reported measures may better predict survival.
Listen now: ja.ma/49M1vdV
Ade Adamson, MD, speaks with author Emily Baumrin, MD, MSCE, about how patient-reported measures may better predict survival.
Listen now: ja.ma/49M1vdV
In cutaneous cutaneous chronic graft-vs-host disease, discordance in clinician vs patient treatment response was common, especially in sclerotic disease; both measures were independently associated with survival. ja.ma/3LEPsY4
January 21, 2026 at 4:30 PM
In cutaneous cutaneous chronic graft-vs-host disease, discordance in clinician vs patient treatment response was common, especially in sclerotic disease; both measures were independently associated with survival. ja.ma/3LEPsY4
Once-daily oral ICP-332, a tyrosine kinase 2 inhibitor, showed favorable safety and significantly improved disease severity versus placebo in adults with moderate to severe #AtopicDermatitis.
ja.ma/45ZPrET
ja.ma/45ZPrET
January 18, 2026 at 3:00 PM
Once-daily oral ICP-332, a tyrosine kinase 2 inhibitor, showed favorable safety and significantly improved disease severity versus placebo in adults with moderate to severe #AtopicDermatitis.
ja.ma/45ZPrET
ja.ma/45ZPrET
In this episode of the JAMA Dermatology Author Interviews podcast, Arash Mostaghimi, MD, MPH, discusses trends in advanced practice clinician involvement and specialty drug spending in dermatology with host Ade Adamson, MD, MPP.
🎧 Listen now:
ja.ma/3LR4Ssa
🎧 Listen now:
ja.ma/3LR4Ssa
January 17, 2026 at 2:00 PM
In this episode of the JAMA Dermatology Author Interviews podcast, Arash Mostaghimi, MD, MPH, discusses trends in advanced practice clinician involvement and specialty drug spending in dermatology with host Ade Adamson, MD, MPP.
🎧 Listen now:
ja.ma/3LR4Ssa
🎧 Listen now:
ja.ma/3LR4Ssa
Between 2013 and 2022, the share of #Dermatology specialty drug spending by advanced practice clinicians rose from 10% to 31%, driven by a faster increase in APC numbers and prescribing intensity compared to physicians. ja.ma/3NmRblg
January 16, 2026 at 3:00 PM
Between 2013 and 2022, the share of #Dermatology specialty drug spending by advanced practice clinicians rose from 10% to 31%, driven by a faster increase in APC numbers and prescribing intensity compared to physicians. ja.ma/3NmRblg
Activating #EGFR variants were identified in early-onset, severe generalized #AcanthosisNigricans with pulmonary nodules; EGFR inhibitor therapy improved both skin and lung disease. ja.ma/4bw0Rnp
January 15, 2026 at 3:00 PM
Activating #EGFR variants were identified in early-onset, severe generalized #AcanthosisNigricans with pulmonary nodules; EGFR inhibitor therapy improved both skin and lung disease. ja.ma/4bw0Rnp
Once-daily oral ICP-332, a tyrosine kinase 2 inhibitor, showed favorable safety and significantly improved disease severity versus placebo in adults with moderate to severe #AtopicDermatitis.
ja.ma/4qRwGeK
ja.ma/4qRwGeK
January 14, 2026 at 8:36 PM
Once-daily oral ICP-332, a tyrosine kinase 2 inhibitor, showed favorable safety and significantly improved disease severity versus placebo in adults with moderate to severe #AtopicDermatitis.
ja.ma/4qRwGeK
ja.ma/4qRwGeK
Eosinophilic fasciitis (EF) is a rare disease in which the fascia, the tissue that covers the muscles, becomes inflamed.
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
January 10, 2026 at 3:00 PM
Eosinophilic fasciitis (EF) is a rare disease in which the fascia, the tissue that covers the muscles, becomes inflamed.
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
📄 This Patient Page describes the symptoms, diagnosis, and treatment of eosinophilic fasciitis.
ja.ma/456KTwd
Case report describes a patient in his 50s with immunoglobulin A vasculitis with monoclonal B-cell lymphocytosis who was successfully treated with zanubrutinib after failure of multiple treatments. ja.ma/49HVRuF
January 9, 2026 at 3:00 PM
Case report describes a patient in his 50s with immunoglobulin A vasculitis with monoclonal B-cell lymphocytosis who was successfully treated with zanubrutinib after failure of multiple treatments. ja.ma/49HVRuF
An adolescent female presented with 3 days of progressive abdominal pain and reported that a rash first appeared nearly 1 year earlier on her left wrist and gradually spread over several weeks.
What is your diagnosis? ja.ma/4qItEcH
What is your diagnosis? ja.ma/4qItEcH
January 8, 2026 at 3:00 PM
An adolescent female presented with 3 days of progressive abdominal pain and reported that a rash first appeared nearly 1 year earlier on her left wrist and gradually spread over several weeks.
What is your diagnosis? ja.ma/4qItEcH
What is your diagnosis? ja.ma/4qItEcH
Transcutaneous auricular vagus nerve stimulation improved facial erythema, flushing, and related systemic symptoms among patients with patients with erythematotelangiectatic #rosacea compared to sham treatment.
ja.ma/3Z01e20
ja.ma/3Z01e20
January 8, 2026 at 1:00 PM
Transcutaneous auricular vagus nerve stimulation improved facial erythema, flushing, and related systemic symptoms among patients with patients with erythematotelangiectatic #rosacea compared to sham treatment.
ja.ma/3Z01e20
ja.ma/3Z01e20
Systematic review: Accurate classification of dermatologic conditions using International Classification of Diseases (ICD) codes is essential for research that uses large administrative datasets. ja.ma/4qANZRk
January 7, 2026 at 5:00 PM
Systematic review: Accurate classification of dermatologic conditions using International Classification of Diseases (ICD) codes is essential for research that uses large administrative datasets. ja.ma/4qANZRk
Among bionaive patients with #Psoriasis in Denmark, ustekinumab had superior drug survival compared with adalimumab and secukinumab over 5 years. ja.ma/45kP3AP
January 7, 2026 at 4:30 PM
Among bionaive patients with #Psoriasis in Denmark, ustekinumab had superior drug survival compared with adalimumab and secukinumab over 5 years. ja.ma/45kP3AP
A woman in her 70s presented with a 5-year history of pruritic, thickened plaques involving the trunk and extremities. Despite intermittent treatment with antihistamines and glucocorticoids, the condition progressed.
Read the full case report: ja.ma/49kbXJD
Read the full case report: ja.ma/49kbXJD
January 7, 2026 at 2:00 PM
A woman in her 70s presented with a 5-year history of pruritic, thickened plaques involving the trunk and extremities. Despite intermittent treatment with antihistamines and glucocorticoids, the condition progressed.
Read the full case report: ja.ma/49kbXJD
Read the full case report: ja.ma/49kbXJD
Psoriasis patients treated with ustekinumab had a lower five-year risk of developing cancer (excluding nonmelanoma skin cancer) compared to those on adalimumab, while risk for secukinumab was similar but limited by small sample size. ja.ma/49ooiMZ
January 7, 2026 at 12:00 PM
Psoriasis patients treated with ustekinumab had a lower five-year risk of developing cancer (excluding nonmelanoma skin cancer) compared to those on adalimumab, while risk for secukinumab was similar but limited by small sample size. ja.ma/49ooiMZ
Acne keloidalis nuchae (AKN) is a chronic skin condition characterized by inflamed hair follicles that can cause hair loss and substantial scarring.
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
January 4, 2026 at 1:00 PM
Acne keloidalis nuchae (AKN) is a chronic skin condition characterized by inflamed hair follicles that can cause hair loss and substantial scarring.
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
This Patient Page describes the symptoms, diagnosis, and treatment of AKN. ja.ma/4bfbuuD
Lamellar ichthyosis (LI) is a rare autosomal recessive disorder characterized by widespread, thick, platelike scales.
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
January 3, 2026 at 1:00 PM
Lamellar ichthyosis (LI) is a rare autosomal recessive disorder characterized by widespread, thick, platelike scales.
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
This case report describes 2 siblings in their 20s with lamellar ichthyosis treated with acitretin and dupilumab. ja.ma/45mH99S
The EBSdart scoring tool reliably measures disease severity in epidermolysis bullosa simplex across age groups, showing strong interrater agreement and generalizability, and may aid future clinical trials and therapy development.
ja.ma/49j9KhF
ja.ma/49j9KhF
January 2, 2026 at 2:00 PM
The EBSdart scoring tool reliably measures disease severity in epidermolysis bullosa simplex across age groups, showing strong interrater agreement and generalizability, and may aid future clinical trials and therapy development.
ja.ma/49j9KhF
ja.ma/49j9KhF